NDC 66993-360

Amphetamine Extended-Release Oral Suspension

Amphetamine

Amphetamine Extended-Release Oral Suspension is a Oral Suspension, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Prasco Laboratories. The primary component is Amphetamine.

Product ID66993-360_47b2c382-7bf4-4264-a567-e81ef6c68b7a
NDC66993-360
Product TypeHuman Prescription Drug
Proprietary NameAmphetamine Extended-Release Oral Suspension
Generic NameAmphetamine
Dosage FormSuspension, Extended Release
Route of AdministrationORAL
Marketing Start Date2019-12-12
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA204325
Labeler NamePrasco Laboratories
Substance NameAMPHETAMINE
Active Ingredient Strength1 mg/mL
Pharm ClassesCentral Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
DEA ScheduleCII
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 66993-360-87

450 mL in 1 BOTTLE, GLASS (66993-360-87)
Marketing Start Date2019-12-12
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
AMPHETAMINE1.25 mg/mL

Pharmacological Class

  • Central Nervous System Stimulant [EPC]
  • Central Nervous System Stimulation [PE]

NDC Crossover Matching brand name "Amphetamine Extended-Release Oral Suspension" or generic name "Amphetamine"

NDCBrand NameGeneric Name
70165-003Adzenys ERAmphetamine
70165-005Adzenys XR-ODTAmphetamine
70165-010Adzenys XR-ODTAmphetamine
70165-015Adzenys XR-ODTAmphetamine
70165-020Adzenys XR-ODTAmphetamine
70165-025Adzenys XR-ODTAmphetamine
70165-030Adzenys XR-ODTAmphetamine
66993-360Amphetamine Extended-Release Oral SuspensionAmphetamine
69238-1563Amphetamine SulfateAmphetamine
69238-1564Amphetamine SulfateAmphetamine
69452-227Amphetamine SulfateAmphetamine
69452-228Amphetamine SulfateAmphetamine
27808-102Dyanavel XRamphetamine

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.